In 2017, after a formal topic nomination and selection process, ASH initiated its first guideline development effort on a malignant topic: acute myeloid leukemia in older adults. This topic was selected as clinically important and largely unaddressed by existing guidelines. In 2018, a guideline panel composed of research experts, clinicians, and a patient representative prioritized clinical questions. Systematic evidence review is supported by the McMaster University GRADE Centre. By December 2019, draft recommendations are expected to be available for public comment.
In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice.